首页> 外文OA文献 >Safety and Efficacy of Plerixafor (Mozobil) Addition to Chemotherapy and Growth Factor Stem Cell Mobilization Regimens in Patients with Low Pre-CD34 Counts Undergoing Stem Cell Collection Prior to Autologous Stem Cell Transplantation

【2h】

Safety and Efficacy of Plerixafor (Mozobil) Addition to Chemotherapy and Growth Factor Stem Cell Mobilization Regimens in Patients with Low Pre-CD34 Counts Undergoing Stem Cell Collection Prior to Autologous Stem Cell Transplantation

机译：Plerixafor（Mozobil）除化学疗法和生长因子干细胞动员方案之外的安全性和有效性，对于自体干细胞移植前接受干细胞收集的低CD34计数前患者进行干细胞收集。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Bayer Ruthee-Lu; Keyzner Alla; Donahue Laura; Elera Claudia; Roddy Rose;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization. [J] . Dugan MJ, Maziarz RT, Bensinger WI, Bone marrow transplantation . 2010,第1期

机译：培乐沙福（Mozobil）与化学疗法和G-CSF联用的安全性和初步疗效：一项针对多发性骨髓瘤和非霍奇金淋巴瘤的干细胞动员患者的开放标签，多中心，探索性试验。
2. Efficacy and safety of plerixafor for the mobilization/collection of peripheral hematopoietic stem cells for autologous transplantation in Japanese patients with multiple myeloma [J] . Masaki Ri, Kosei Matsue, Kazutaka Sunami, International journal of hematology . 2017,第4期

机译：普利克递对多发性骨髓瘤患者自体移植动员/收集外周造血干细胞的疗效和安全性
3. EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors [J] . Karres Dominik, Ali Sahra, Hennik Paula B., The oncologist . 2020,第6期

机译：EMA推荐用于增强淋巴瘤儿童的收集和随后的自体移植的血管基硼（Mozobil）的血杂化干细胞的动员
4. Phase 1 Trial of Retroviral-Mediated Transfer of the Human MDR-1 In Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation [C] . Charles Hesdorffer, Janet Ayello, Maureen Ward, Keio International Symposium for Life Sciences and Medicine . 2000

机译：逆转录病毒介导的人MDR-1转移的第1期试验在接受高剂量化疗和自体干细胞移植的患者中
5. Factors influencing the incidence and severity of oral mucositis in patients undergoing autologous stem cell transplantation. [D] . Salvador, Prisco T. 2004

机译：自体干细胞移植患者口腔黏膜炎发生率和严重程度的影响因素。
6. EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors [O] . Dominik Karres, Sahra Ali, Paula B. van Hennik, 2020

机译：EMA推荐的Plerixafor（Mozobil）的儿科适应症可增强动员造血干细胞的动员能力以收集和随后进行淋巴瘤或恶性实体瘤儿童的自体移植。
7. Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization [O] . M J Dugan, R T Maziarz, W I Bensinger, 2009

机译：Plerixafor（Mozobil）与化疗和G-CSF组合的安全性和初步疗效：多种骨髓瘤和非霍奇金淋巴瘤患者的开放标签，多中心，探索性试验，接受干细胞动员

Safety and Efficacy of Plerixafor (Mozobil) Addition to Chemotherapy and Growth Factor Stem Cell Mobilization Regimens in Patients with Low Pre-CD34 Counts Undergoing Stem Cell Collection Prior to Autologous Stem Cell Transplantation

著录项

相似文献

相关主题

期刊订阅